MSB 0.69% $1.46 mesoblast limited

Ann: FDA Clears Phase 3 Heart Failure Trial , page-18

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 173 Posts.
    On 7 July 2011 MSB announced a clearing of a phase 3 trial for bone marrow. There hasn't been an announcement since.

    I attempted several times to contact the company to find out what happened with no reply.

    I would love to buy this stock as I believe the technology - fundamentally it is difficult to invest in a company that deceives shareholders.

    I realise that bone marrow is a drop in the ocean in terms of revenue. For me, I just need to trust management.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.